Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

Russell J. Schilder,John A. Blessing,Mark Morgan,Charles E. Mangan,Janet S. Rader

Gynecologic Oncology（2000）

引用 91|浏览11

暂无评分

摘要

Purpose. A multicenter Phase II trial was conducted to evaluate the activity and toxicity of gemcitabine in patients with previously treated squamous cell carcinoma of the uterine cervix.

查看译文

关键词

adverse effect,renal function,phase ii study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要